A company files for bankruptcy. Its owners try to get immunity anyway.
2019
Year Purdue Pharma filed for bankruptcy, facing mass opioid litigation
$0
Bankruptcy filings made personally by Sackler family members — none
2024
Year the US Supreme Court rejected the original settlement's family shield
$7.4B
Value of the revised settlement ultimately reached
FACTPurdue Pharma, maker of OxyContin, filed for corporate bankruptcy in 2019 while facing sweeping litigation over its role in the US opioid crisis.
FACTThe Sackler family, which owned and controlled Purdue, did not personally file for bankruptcy. Despite that, the original settlement plan sought to grant Sackler family members personal, blanket immunity from all future opioid-related lawsuits, in exchange for a cash contribution to the settlement fund.
INFERENCEThis is the structural core of the case: US bankruptcy law exists to give relief to debtors who file for bankruptcy. The original plan tried to extend that same legal shield to people (the Sacklers) who were not themselves debtors and had not themselves filed — using their company's bankruptcy as a vehicle to protect assets the family held personally, separate from the company.